Prime Medicine (PRME) Capital Expenditures (2021 - 2026)
Prime Medicine (PRME) recorded Capital Expenditures of $46,000 in Q2 2026, down 97.1% from $1.57 million a year earlier and down 78.5% from the prior quarter.
Powered by 
Analysis
Prime Medicine (PRME) Capital Expenditures (2021 - 2026) Analysis & Trends
On a TTM basis, Prime Medicine's Capital Expenditures came in at $797,000 as of Jun 30, 2026, down 88.7% year-over-year; for FY2025, it came in at $4.53 million, down 37.9% from FY2024.
- Annual Capital Expenditures has declined for three straight years, though with a five-year compound annual growth rate of 48.0% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $7.29 million in FY2024 (-16.4%), $8.72 million in FY2023 (-45.8%), $16.1 million in FY2022 (+287.8%) and $4.15 million in FY2021 (+549.5%).
- The Q2 2026 figure is the lowest quarterly Capital Expenditures in data going back to Q4 2021.
- On a year-over-year basis, Capital Expenditures has declined for five consecutive quarters, with an average decline of 53.1% over the last eight quarters.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 18.4% in Q1 2023, against a decline of 97.1% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $214,000 (Q1 2026), $290,000 (Q4 2025) and $247,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.71 Bn | 1,136.29 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 647.75 Bn | 567.61 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 503.60 Bn | 476.71 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 368.10 Bn | 322.48 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 303.19 Bn | 267.18 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 268.04 Bn | 241.73 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 242.69 Bn | 198.09 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.89 Bn | 169.09 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 173.31 Bn | 119.95 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Prime Medicine | 651.30 Mn | 29.77 Mn | - | 46,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46,000.00 |
| Mar 31, 2026 | 214,000.00 |
| Dec 31, 2025 | 290,000.00 |
| Sep 30, 2025 | 247,000.00 |
| Jun 30, 2025 | 1.57 Mn |
| Mar 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 1.79 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 2.32 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Sep 30, 2023 | 2.91 Mn |
| Jun 30, 2023 | 1.98 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 4.81 Mn |
| Sep 30, 2022 | 4.79 Mn |
| Jun 30, 2022 | 4.80 Mn |
| Mar 31, 2022 | 1.69 Mn |
| Dec 31, 2021 | 382,000.00 |
API Access
Prime Medicine Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PRME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PRME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PRME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();